PRELIMINARY-REPORT OF SAFETY FOR A PHASE-II TRIAL OF BREQUINAR SODIUM (DUP 785, NSC 368390) IN REFRACTORY SOLID TUMORS

被引：0
|
作者：
DALLAIRE, BK [1 ]
VARNS, CL [1 ]
GALBRAITH, DW [1 ]
WIELGOSZ, G [1 ]
ADAMS, DB [1 ]
BRENTZEL, HJ [1 ]
LYNCH, WJ [1 ]
CARLSON, R [1 ]
SISK, R [1 ]
AZARNIA, N [1 ]
BIGELOW, R [1 ]
BARBU, M [1 ]
GYVES, JW [1 ]
GRILLOLOPEZ, AJ [1 ]
机构：
[1] DUPONT PHARMACEUT CO,WILMINGTON,DE
来源：
CLINICAL RESEARCH | 1991年 / 39卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A375 / A375
页数：1
相关论文
共 50 条
  • [31] PHASE-II STUDY OF ICRF-159 (NSC-129943) IN HUMAN SOLID TUMORS
    BELLET, RE
    MASTRANGELO, MJ
    CREECH, RH
    ENGSTROM, PF
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1975, 16 (MAR): : 224 - 224
  • [32] A PHASE-II CLINICAL-TRIAL OF MITOXANTRONE IN SOLID TUMORS AND LYMPHOMAS
    EARL, HM
    AMLOT, PL
    RUBENS, RD
    BRITISH JOURNAL OF CANCER, 1982, 45 (04) : 636 - 637
  • [33] PHASE-II TRIAL OF MITOGUAZONE IN PATIENTS WITH REFRACTORY GERM-CELL TUMORS
    CHUN, H
    BOSL, GJ
    CANCER TREATMENT REPORTS, 1985, 69 (04): : 461 - 462
  • [34] MULTICENTER PHASE-II TRIAL OF BREQUINAR SODIUM IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    URBA, S
    DOROSHOW, J
    CRIPPS, C
    ROBERT, F
    VELEZGARCIA, E
    DALLAIRE, B
    ADAMS, D
    CARLSON, R
    GRILLOLOPEZ, A
    GYVES, J
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 31 (02) : 167 - 169
  • [35] CYCLOPHOSPHAMIDE VERSUS IFOSFAMIDE - PRELIMINARY-REPORT OF A RANDOMIZED PHASE-II TRIAL IN ADULT SOFT-TISSUE SARCOMAS
    BRAMWELL, VHC
    MOURIDSEN, HT
    SANTORO, A
    BLACKLEDGE, G
    SOMERS, R
    THOMAS, D
    SYLVESTER, R
    VANOOSTEROM, A
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1986, 18 : S13 - S16
  • [36] PHASE-II STUDY OF AMSACRINE IN SOLID TUMORS - A REPORT OF THE EORTC EARLY CLINICAL TRIAL-GROUP
    DEJAGER, R
    SIEGENTHALER, P
    CAVALLI, F
    KLEPP, O
    BRAMWELL, V
    JOSS, R
    ALBERTO, P
    VANGLABBEKE, M
    RENARD, J
    ROZENCWEIG, M
    HANSEN, HH
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (02): : 289 - 293
  • [37] 4'-EPI-DOXORUBICIN - A CLINICAL PHASE-II TRIAL IN SOLID TUMORS
    SCHUTTE, J
    NIEDERLE, N
    GRUNENBERG, B
    KRISCHKE, W
    SEEBER, S
    SCHMIDT, CG
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1984, 107 (01) : 38 - 41
  • [38] DISEASE ORIENTED PHASE-II TRIAL WITH ETOPOSIDE (NSC-141540) IN CISPLATIN REFRACTORY OVARIAN-CANCER
    KUHNLE, H
    ACHTERRATH, W
    FRISCHKORN, R
    TUMORDIAGNOSTIK & THERAPIE, 1984, 5 (04) : 152 - 155
  • [39] 5-AZACYTIDINE (NSC-102816) IN REFRACTORY GERM-CELL TUMORS - A PHASE-II TRIAL OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP
    ROTH, BJ
    ELSON, P
    SLEDGE, GW
    EINHORN, LH
    TRUMP, DL
    INVESTIGATIONAL NEW DRUGS, 1993, 11 (2-3) : 201 - 202
  • [40] PHASE-II TRIAL OF TOPOTECAN IN PATIENTS WITH CISPLATIN-REFRACTORY GERM-CELL TUMORS
    PUC, HS
    BAJORIN, DF
    BOSL, GJ
    AMSTERDAM, A
    MOTZER, RJ
    INVESTIGATIONAL NEW DRUGS, 1995, 13 (02) : 163 - 165
12345